Designing a twenty-first century Medicare prescription drug benefit: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, April 8, 2003, Volumes 73-78
U.S. G.P.O., 2003 - Medical - 76 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
AARP additional administrative costs adverse selection affordable Alzheimer's disease Barton believe beta blocker beta-blocker Bilirakis billion budget Burr Buyer Capps Chairman choice chronic coinsurance Congress Crippen David Herman Doctor Crippen drug costs drug plan efit elderly employers enrolled enrollees Federal fee-for-service Medicare ficiaries formularies going health insurance healthcare hearing Herman HMOs income increase issue long-term look M+C program managed care plans means testing Medi Medicaid Medicare beneficiaries Medicare drug benefit Medicare prescription drug Medicare program Medicare's medicine Michael Bilirakis Norwood Olsen opening statement option out-of-pocket outpatient patients payment PBMs percent pharmaceutical premium prescription drug benefit prescription drug coverage private insurance private plans private sector problem proposal QIOs retirees risk scription drug benefit Seniors Coalition Social Security spending Subcommittee talk tax cuts Thank therapy there's tion traditional Medicare trillion Vladek